Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
医学
赛马鲁肽
2型糖尿病
内科学
临床试验
糖尿病
临床研究阶段
相（物质）
口服
随机对照试验
作者
Julio Rosenstock,Julio Rosenstock,Daisuke Yabe,David A. Cox,Jianghao Li,Max Denning,Wen-Shuo Wu,Rong Liu,Youna Zhao,Federico Pérez Manghi,Franklin Ábalos,P. Costanzo,Ana Chiesa,Natacha Maldonado,Susana Salzberg,Claudia Goycoa,Horacio Sessa,Diego Aizenberg,Marisa L. Vico,Fernando Guerlloy
PDF的下载单位、IP信息已删除
(2025-6-4)
zhangchi
清爽老九
FIN
GingerF
压寨猫夫人
Nole
X的三次方
DW
渡人舟
Kao
skearthy
DearG
yeruotong
OK
sissiarno
My_magnum_opus
初景
Freya1528
HFH
max
皖公网安备34019202002308
